Ent-16β,17-Dihydroxykauran-19-oic acid

Ent-16β,17-Dihydroxykauran-19-oic acid is an anti-inflammatory agent, which can be isolated from Siegesbeckia pubescens herb. ent-16β,17-Dihydroxykauran-19-oic acid inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglia[1].

Product Specifications

CAS Number

[3301-61-9]

UNSPSC

12352211

Target

Others

Type

Natural Products

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/ent-16β-17-dihydroxykauran-19-oic-acid.html

Purity

98.0

Solubility

10 mM in DMSO

Smiles

C[C@]12[C@@]3([H])[C@]4(CC[C@]1([H])[C@@](C)(CCC2)C(O)=O)C[C@@](O)([C@@](CC3)([H])C4)CO

Molecular Formula

C20H32O4

Molecular Weight

336.47

References & Citations

[1]Lee M, et al. ent-kaurane and ent-pimarane diterpenes from Siegesbeckia pubescens inhibit lipopolysaccharide-induced nitric oxide production in BV2 microglia. Biol Pharm Bull. 2014;37 (1) :152-7.